Unilateral vs Bilateral Laparoscopic Ovarian Drilling In Clomiphene Citrate Resistant Cases of Polycystic Ovarian Syndrome
NCT06537102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2024-08-05
Summary
The aim of the current study is to compare the efficacy of laparoscopic unilateral ovarian drilling with bilateral ovarian drilling in clomiphene citrate resistant cases of polycystic ovarian syndrome in terms of clinical response (regularity of the cycle), change in biochemical parameters, ovulation rate over six months, pregnancy rate within six months.
Conditions
- Laparoscopic
- Ovarian Drilling
- Clomiphene Citrate
- Polycystic Ovarian Syndrome
- Unilateral
- Bilateral
Interventions
- OTHER
-
Unilateral laparoscopic ovarian drilling
Laparoscopic drilling was performed under general anesthesia as follows: 10-mm subumbilical entry and two 5-mm secondary ports in the lower part of the abdomen just above the anterior superior iliac spine. The laparoscope is introduced through the subumbilical port, and secondary ports was used for introduction of the instruments, the type of needle was an insulated unipolar needle electrode with a non-insulated distal end. We are planning to use the least thermal effective dose which is 60 J/cm3 of ovarian tissue. The number of punctures (Np) per ovary was calculated according to the following formula: N p = 60 J/cm3/40 W × 4 s, with 3 mm diameter and 4 mm depth for each puncture using power setting of 300 W for 2-4 s. Unilateral: was done on the larger ovary.
- OTHER
-
Bilateral laparoscopic ovarian drilling
Laparoscopic drilling was performed under general anesthesia as follows: 10-mm subumbilical entry and two 5-mm secondary ports in the lower part of the abdomen just above the anterior superior iliac spine. The laparoscope is introduced through the subumbilical port, and secondary ports was used for introduction of the instruments, the type of needle was an insulated unipolar needle electrode with a non-insulated distal end. We are planning to use the least thermal effective dose which is 60 J/cm3 of ovarian tissue. The number of punctures (Np) per ovary was calculated according to the following formula: N p = 60 J/cm3/40 W × 4 s, with 3 mm diameter and 4 mm depth for each puncture using power setting of 300 W for 2-4 s. Bilateral: Using dose adjusted according to ovarian volume.
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2023-06-01
- Completion
- 2023-06-01
Countries
- Egypt
Study Locations
More Related Trials
-
Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.
NCT02304536 ·Status: UNKNOWN ·Phase: PHASE3
-
Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome
NCT02381184 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome
NCT01693289 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)
NCT00969631 ·Status: COMPLETED ·Phase: NA
-
Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.
NCT00956267 ·Status: COMPLETED ·Phase: NA
-
Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients
NCT06861803 ·Status: NOT_YET_RECRUITING
-
Ovulation Induction in Clomiphene Citrate Resistant PCO Women
NCT02341703 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose Adjusted vs. Fixed Dose Unilateral Laparoscopic Ovarian Drilling in PCOS Patients
NCT04021940 ·Status: UNKNOWN ·Phase: NA
-
Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.
NCT04887402 ·Status: UNKNOWN
-
Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.
NCT02304107 ·Status: COMPLETED ·Phase: PHASE3
-
Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?
NCT03357640 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
NCT01909141 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS
NCT02458963 ·Status: WITHDRAWN ·Phase: PHASE4
-
LOD Before IVF/ICSI in PCOS Patients With High AMH
NCT03358199 ·Status: COMPLETED
-
Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome
NCT01679574 ·Status: COMPLETED ·Phase: NA
-
Letrozole Dose Increments in PCOS Patients Resistant to Letrozole
NCT06403488 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome
NCT03135301 ·Status: UNKNOWN ·Phase: PHASE3
-
Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome
NCT00911313 ·Status: COMPLETED ·Phase: NA
-
Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS Women
NCT02140398 ·Status: UNKNOWN ·Phase: PHASE4
-
Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women
NCT01793038 ·Status: UNKNOWN ·Phase: NA
-
LOD vs Gn in Anovulatory PCOs Resistant to First Line Agents
NCT04325295 ·Status: UNKNOWN ·Phase: NA
-
Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome
NCT06405178 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance
NCT04834791 ·Status: COMPLETED ·Phase: PHASE4
-
Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome
NCT01157312 ·Status: COMPLETED ·Phase: NA
-
Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS
NCT07255911 ·Status: RECRUITING ·Phase: NA